AstraZeneca's Lynparza Slows Spread of Inherited Breast Cancer - Bloomberg

Bloomberg

AstraZeneca's Lynparza Slows Spread of Inherited Breast Cancer Bloomberg AstraZeneca Plc showed that its drug Lynparza slowed progression of a devastating, inherited form of breast cancer that typically strikes younger women, potentially opening up a new market for a pill originally approved to treat ovarian tumors. A study ... AstraZeneca's Lynparza Slows Breast Cancer Caused By BRCA Mutations By 42%Forbes Olaparib Associated With Improved Quality of Life in Ovarian CancerCancer Network Olaparib Shows Promise as Long-term Maintenance Therapy in Relapsed Serous Ovarian Cancer in Final Study 19 ...Targeted Oncology Oncology Nurse Advisor -FiercePharma -ETHealthworld.com -EurekAlert (press release) all 13 news articles »

from Health - Google News http://ift.tt/2rpAB84